| Product NDC: | 0517-0805 |
| Proprietary Name: | Atropine Sulfate |
| Non Proprietary Name: | Atropine Sulfate |
| Active Ingredient(s): | .4 mg/.5mL & nbsp; Atropine Sulfate |
| Administration Route(s): | INTRAMUSCULAR; INTRAVENOUS; SUBCUTANEOUS |
| Dosage Form(s): | INJECTION, SOLUTION |
| Coding System: | National Drug Codes(NDC) |
| Product NDC: | 0517-0805 |
| Labeler Name: | American Regent, Inc. |
| Product Type: | HUMAN PRESCRIPTION DRUG |
| FDA Application Number: | |
| Marketing Category: | UNAPPROVED DRUG OTHER |
| Start Marketing Date: | 19921101 |
| Package NDC: | 0517-0805-25 |
| Package Description: | 25 AMPULE in 1 BOX (0517-0805-25) > .5 mL in 1 AMPULE |
| NDC Code | 0517-0805-25 |
| Proprietary Name | Atropine Sulfate |
| Package Description | 25 AMPULE in 1 BOX (0517-0805-25) > .5 mL in 1 AMPULE |
| Product NDC | 0517-0805 |
| Product Type Name | HUMAN PRESCRIPTION DRUG |
| Non Proprietary Name | Atropine Sulfate |
| Dosage Form Name | INJECTION, SOLUTION |
| Route Name | INTRAMUSCULAR; INTRAVENOUS; SUBCUTANEOUS |
| Start Marketing Date | 19921101 |
| Marketing Category Name | UNAPPROVED DRUG OTHER |
| Labeler Name | American Regent, Inc. |
| Substance Name | ATROPINE SULFATE |
| Strength Number | .4 |
| Strength Unit | mg/.5mL |
| Pharmaceutical Classes | Anticholinergic [EPC],Cholinergic Antagonists [MoA],Cholinergic Muscarinic Antagonist [EPC],Cholinergic Muscarinic Antagonists [MoA] |